M&A

Genzyme seen more attractive to Sanofi than Glaxo
Yahoo/Reuters
Mon, 07/26/10 - 11:39 am
Genzyme
M&A
Sanofi
GSK
Biogen Idec
Celgene
Don't Look for Strategy Behind Sanofi's Bid for Genzyme: It's All About the Cash
BNET Pharma
Mon, 07/26/10 - 11:25 am
Genzyme
Sanofi
M&A
A.M. Vitals: Could Genzyme Attract Other Suitors?
WSJ Online
Mon, 07/26/10 - 11:04 am
Genzyme
M&A
GSK
Sanofi
JNJ
Sanofi-Aventis’s Biotech Play for Genzyme
NY Times, NY
Mon, 07/26/10 - 10:58 am
M&A
Sanofi
Genzyme
Roche Profit Up on Genentech Synergies
NY Times, NY
Thu, 07/22/10 - 08:53 am
Roche
earnings
M&A
Genentech
Milestones mitigate risk in biotech deals
Fierce Biotech
Thu, 07/22/10 - 08:51 am
biotech
M&A
milestone payments
Lilly Announces Completion of Alnara Acquisition
Yahoo
Wed, 07/21/10 - 08:00 am
Eli Lilly
M&A
Alnara
Cypress Bioscience confirms Ramius' buyout offer
Yahoo/AP
Tue, 07/20/10 - 03:34 pm
M&A
Cypress Bioscience
Ramius
Novartis chief stands firm on Alcon bid
Fierce Pharma
Tue, 07/20/10 - 11:03 am
Novartis
Joe Jimenez
M&A
Alcon
Cypress rallies on buyout bid; drug stocks climb
Marketwatch
Mon, 07/19/10 - 11:45 am
drug stocks
Cypress Bioscience
M&A
Novartis CEO says Alcon minority offer 'fair'-paper
Reuters
Mon, 07/19/10 - 09:52 am
Novartis
Alcon
M&A
Joe Jimenez
Ramius unit bids $4-share for Cypress Bioscience
Marketwatch
Mon, 07/19/10 - 09:50 am
Ramius
Cypress Bioscience
M&A
Charles River Shareholders Says Wuxi Deal Is Inadequate
Outsourcing Pharma
Mon, 07/19/10 - 09:22 am
WuXi PharmaTech
Charles River Laboratories
M&A
Mylan buys $550m passport to US injectables market
InPharmaTechnologist
Fri, 07/16/10 - 09:16 am
Mylan
M&A
injectables
Bioniche Pharma
Sepracor to become Sunovion Pharmaceuticals
Boston.com
Thu, 07/15/10 - 09:33 am
Sepracor
Sunovion
M&A
Dainippon Sumitomo
Alcon's Independent Directors Call Novartis Purchase Offer `Unacceptable'
Bloomberg
Thu, 07/15/10 - 08:51 am
Alcon
Novartis
M&A
Charles River and WuXi Merger: Sum Is Greater Than the Parts
Seeking Alpha
Wed, 07/14/10 - 10:40 am
M&A
Charles River Laboratories
WuXi PharmaTech
Charles River: Wuxi may add $100M to yearly sales
Yahoo/AP
Tue, 07/13/10 - 12:29 pm
Charles River Laboratories
M&A
WuXi PharmaTech
Covidien completes $2.6B purchase of ev3
Mon, 07/12/10 - 10:40 pm
Covidien
ev3
M&A
Urodynamix Technologies signs agreement with Hegln
Mon, 07/12/10 - 10:26 pm
Venturi Ventures
Hegln
China
M&A

Pages